FloTrac
DeviceFor patients belonging to case group a Pulse Contour Analysis was adopted for optimize fluid administration
NCT Number: NCT03090399
In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For patients belonging to case group a Pulse Contour Analysis was adopted for optimize fluid administration
Time frame: up to 30 days
Time frame: up to 12 weeks
Looking for future studies?
Notify MeFondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07840040
Fluid Responsiveness, Hemodynamics
Pilsen, Czech Republic, Czechia
View Trial DetailsNCT07790263
Aging, Autonomic Nervous System
Taoyuan, Guishan, Taiwan
View Trial DetailsNCT07260890
Digestive System Diseases, Fluid Therapy
Iksan, Jeollabuk-do, South Korea
View Trial DetailsNCT04291196
Anxiety, Anxiety Disorders
Toronto, Ontario, Canada
View Trial Details